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Background: To predict major adverse cardiac events (MACE) in hypertrophic cardiomyopathy (HCM) patients we measured two dimensional (2D), 
global, longitudinal strain (GLS) and global circumferential strain (GCS) in left ventricular (LV) myocardium using speckle tracking transthoracic 
echocardiography (TTE).
Materials and Methods: A total of 44 consecutive HCM patients (29 males; mean 60 years) underwent TTE (iE-33, Philips) and were followed for 
a median of 29 months.
results: Cox proportional hazard model of univariate analysis revealed that 2D LV GLS (hazard ratio 1.914, 95% confidence interval (CI) 1.136-
3.227, P = 0.015) was a significant predictor for MACE, but 2D LV GCS was not (hazard ratio 1.076, 95%CI 0.989-1.170, P = 0.087). In the Cox 
multivariate analysis, 2D LV GLS was a significant predictor for MACE (hazard ratio 1.966, 95% CI 1.039-3.722, P = 0.038). According to a receiver 
operating characteristic curve, the best cutoff value for 2D LV GLS and GCS to distinguish patients with and without MACE was -9.65% and -29.35% 
with area under the curve, sensitivity and specificity, 0.822, 100%, and 67.6% in 2D LV GLS and 0.687, 100%, and 51.4% in 2D LV GCS, respectively. 
By Kaplan Meier analysis, there were significant differences in the occurrence of MACE between ≤ -9.65% and > 9.65% of 2D LV GLS (P = 0.002) 
and ≤ -29.35% and > 29.35% of 2D LV GCS (P = 0.011) during the follow up period.
conclusions: Both 2D LV GLS and 2D LV GCS (2D LV GLS > 2D LV GCS) can non-invasively predict poor prognosis in HCM patients.
